Medicamentos de actualidad = Drugs of today

• 

  Año 2013, Vol. 49, Número 2

  • Monographs

    • Pasireotide, a multi-somatostatin receptor ligand with potential efficacy for treatment of pituitary and neuroendocrine tumors.

      Richard A. Feelders, Wouter W. de Herder, Sebastian J. Neggers, Aart J. van der Lely, Leo Hofland

      • Resumen

      págs. 89-103

      

    • The development of regorafenib and its current and potential future role in cancer therapy.

      Stephanie Lindsey Davis, Sándor Gail Eckhardt, Wells A. Messersmith, Antonio Jimeno

      • Resumen

      págs. 105-115

      

  • Review

    • 2012 in review - Part II: Overcoming the obstacles in the pharma/biotech industry.

      Xavier Rabasseda, Coia Dulsat, D. P. Navarro, Elisabet Cruces, Ann I. Graul, Charlotte Jago, M. Tracy

      • Resumen

      págs. 117-143

      

  • Biomarkers today

    • Maternal plasma biomarkers for Down syndrome: Present and future.

      Neil David Avent

      • Resumen

      págs. 145-152

      

  • Meeting report

    • A report from the American College of Rheumatology/Asociation of Rheumatology Health Professionals (ACR/ARHP) - 2012 Annual Meeting (November 9-14, 2012 - Washington, D.C.; USA)

      Gary Croasdell

      • Resumen

      págs. 153-155